American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: Editor-in-chief: Samy, I. McFarlane
Open Access
Journal Browser
American Journal of Medical Case Reports. 2014, 2(6), 117-119
DOI: 10.12691/ajmcr-2-6-2
Open AccessCase Report

Diarrhea, Demyelinating Neuropathy and Dyspnea: An Occam’s Razor Dilemma

Abimbola Aderinto-Adike1, , Hung Q Doan1, Cima Nowbakht1, Elizabeth Looke-Stewart1 and Soma Jyothula2

1Houston Methodist Hospital, Department of Medicine, 6565 Fannin Street, Houston TX 77030 USA

2Houston Methodist Hospital, Department of Pulmonary and Transplant Medicine, 6565 Fannin Street, Houston TX 77030 USA

Pub. Date: June 24, 2014

Cite this paper:
Abimbola Aderinto-Adike, Hung Q Doan, Cima Nowbakht, Elizabeth Looke-Stewart and Soma Jyothula. Diarrhea, Demyelinating Neuropathy and Dyspnea: An Occam’s Razor Dilemma. American Journal of Medical Case Reports. 2014; 2(6):117-119. doi: 10.12691/ajmcr-2-6-2


POEMS disease is a rare paraneoplastic syndrome resulting from an underlying plasma cell disorder. We present a unique case of POEMS disease with predominant clinical symptoms of diarrhea and paresthesias.

POEMS disease paraneoplastic disease diarrhea paresthesias shortness of breath

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E, Tsubaki T, Igata A, Ozaki Y. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology. 1984 Jun; 34 (6): 712-20.
[2]  Bardwick P., Zvaifler N., Gill G., Newman D., Greenway, G., Resnick D. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine (Baltimore). 1980 Jul; 59 (4): 311-322.
[3]  Dispenzieri A, Buadi FK. A review of POEMS syndrome. Oncology (Williston Park). 2013 Dec; 27 (12): 1242-50. (1).
[4]  Dispenzieri A. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol. 2014 Feb; 89 (2): 214-23. (2).
[5]  Sekiguchi Y, Misawa S, Shibuya K, Nasu S, Mitsuma S, Iwai Y, Beppu M, Sawai S, Ito S, Hirano S, Nakaseko C, Kuwabara S. Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome. J Neurol Neurosurg Psychiatry. 2013 Dec; 84 (12): 1346-8. (3).
[6]  Li J, Zhou DB. New advances in the diagnosis and treatment of POEMS syndrome. Br J Haematol. 2013 May; 161 (3): 303-15. (4).
[7]  Dupont SA, Dispenzieri A, Mauermann ML, Rabinstein AA, Brown RD Jr. Cerebralinfarction in POEMS syndrome: incidence, risk factors, and imaging characteristics. Neurology. 2009 Oct 20; 73 (16): 1308-12. (5).